Safety and Efficacy Study of Novel Gene Therapy ZM-01 for X-linked Retinoschisis Patients
Clinical trial NCT06066008 · COMPLETED
Trial details
- NCT number
- NCT06066008
- Sponsor
- Zhongmou Therapeutics
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-25
- Primary completion
- 2023-10-31
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.